62 results
Cardiohepatic syndrome is associated with poor prognosis in patients undergoing tricuspid transcatheter edge-to-edge valve repair
27 Jan 2022
As the prognostic role of cardiohepatic syndrome (CHS) has not yet been evaluated, Stolz et al. in the present study assessed its impact on T-TEER outcomes.
Reviewer
Reviewer
Cusp symmetry and coronary ostial eccentricity and its impact on coronary access following TAVR
26 Jan 2022
Recently, coronary access has been recognized as an important consideration in the lifetime management of patients with severe aortic stenosis...
Reviewer
30-day outcomes following transfemoral transseptal transcatheter mitral valve replacement: Intrepid TMVR early feasibility study results
21 Jan 2022
The study by Zahr et al. reports the results of an interim analysis assessing procedural and clinical outcomes at 30-day in 15 patients treated with the newly developed Medtronic Intrepid 35-F trans-femoral transcatheter mitral valve replacement (TMVR) system.
Reviewer
Iatrogenic atrial septal defects following transcatheter mitral valve repair and implications of interventional closures
21 Dec 2021
The authors investigated whether iatrogenic atrial septal defect closure post-transcatheter mitral valve edge-to-edge repair is superior to conservative therapy, and whether outcomes (death/heart failure hospitalization) differ between patients with and without an iASD post-TMVR.
Reviewer
ACTIVATION (percutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION): a randomized clinical trial
19 Oct 2021
In conducting the ACTIVATION trial, Redwood and colleagues seek to complement the existing literature with high-level evidence on whether percutaneous coronary intervention (PCI) prior to TAVR is non-inferior to conservative (no PCI) management.
Reviewer
Reviewer
Valve-in-valve transcatheter aortic valve implantation versus repeat surgical aortic valve replacement in patients with a failed aortic bioprosthesis
24 Sep 2021
Structural valve deterioration remains the Achilles heel of both SAVR and TAVI. Since indications for TAVI have expanded to low-risk patients in 2019, this clinical scenario poses a significant conundrum for physicians and surgeons, as the number of patients undergoing aortic valve interventions continues to grow...
Reviewer
Reviewer
Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement
09 Jul 2021
Read more about the Nordic Aortic Valve Intervention (NOTION) trial to compare clinical outcomes and durability of bioprosthetic aortic valves 8 years after TAVI and SAVR.
Reviewer
Moderate aortic stenosis in patients with heart failure and reduced ejection fraction
08 Jun 2021
The aim of this study was to determine the prognostic impact conferred by the presence of moderate AS on the outcomes of patients with HFrEF.
Reviewer
Impact of anesthesia strategy and valve type on clinical outcomes after transcatheter aortic valve replacement
07 May 2021
The current analysis aimed to compare the safety and efficacy of the Edwards Sapien S3 and Medtronic Corevalve. Furthermore, conscious sedation (CS) and local anaesthesia have been reported to reduce adverse events compared to general anaesthesia (GA) in several observational studies, with a lack of randomised...
Reviewer
Prognostic implications of cardiac damage classification based on computed tomography in severe aortic stenosis
03 May 2021
In the PARTNER II trial, a new staging system of extra-aortic valvular cardiac damage is proposed, using 2 D transthoracic echocardiography and its prognostic value. The purpose of this study is to evaluate the prognostic value of such extra-aortic cardiac damage using MDCT in patients undergoing...
Reviewer
Reviewer
